Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...

The top 10 stock picks include a lot of unfamiliar names, which is to be expected from an Asia-based brokerage. The list ...

BENGALURU: The Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) and CrisprBits Private Limited have signed a ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

CRISPR/Cas9 gene-editing therapy is a groundbreaking technology that enables highly precise modification of disease-causing ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

DUBLIN--(BUSINESS WIRE)--The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Plant Breeding and CRISPR ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...